Madison, CT, United States of America

Neil Connor Payne

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Harvard College, The General Hospital Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil Connor Payne. Retrieved from https://idiyas.com/inventor/neil-connor-payne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil Connor Payne: Innovator in Nrf2 Pathway Modulation

Introduction

Neil Connor Payne is a notable inventor based in Madison, CT (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of the Nrf2 pathway. His work has implications for treating various health conditions, including cancer and neurodegenerative diseases.

Latest Patents

Neil Connor Payne holds 1 patent for his invention titled "Methods and materials for modulating Nrf2 pathway." This patent outlines methods and compounds that can effectively modulate the Nrf2 pathway, which is crucial for cellular defense mechanisms. The application provides innovative approaches for treating cancer and neurodegenerative conditions.

Career Highlights

Throughout his career, Neil has worked with prestigious organizations, including The General Hospital Corporation and Harvard College. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Neil has collaborated with notable colleagues such as Bakhos Tannous and Christian Badr. These partnerships have enriched his research and expanded the impact of his work in the scientific community.

Conclusion

Neil Connor Payne is a distinguished inventor whose work in modulating the Nrf2 pathway holds promise for advancing treatments for serious health conditions. His contributions to biomedical research continue to inspire innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…